Trial · NCT02384941
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in A1C at Week 24 | Placebo | -0.07 | Standard Error 0.036 | percentage of A1C | |
| Change From Baseline in A1C at Week 24 | Sotagliflozin 200 mg | -0.43 | Standard Error 0.036 | percentage of A1C | |
| Change From Baseline in A1C at Week 24 | Sotagliflozin 400 mg | -0.48 | Standard Error 0.036 | percentage of A1C | |
| Percentage of Participants With A1C <7.0% (at Week 24) and No Episode of Severe Hypoglycemia and No Episode of Diabetic Ketoacidosis (DKA) Upto Week 24 | Placebo | 21.6 | percentage of participants | ||
| Percentage of Participants With A1C <7.0% (at Week 24) and No Episode of Severe Hypoglycemia and No Episode of Diabetic Ketoacidosis (DKA) Upto Week 24 | Sotagliflozin 200 mg | 33.5 | percentage of participants | ||
| Percentage of Participants With A1C <7.0% (at Week 24) and No Episode of Severe Hypoglycemia and No Episode of Diabetic Ketoacidosis (DKA) Upto Week 24 | Sotagliflozin 400 mg | 43.5 | percentage of participants | ||
| Absolute Change From Baseline in Body Weight at Week 24 | Placebo | 0.78 | Standard Error 0.187 | kilograms (kg) | |
| Absolute Change From Baseline in Body Weight at Week 24 | Sotagliflozin 200 mg | -1.57 | Standard Error 0.188 | kilograms (kg) | |
| Absolute Change From Baseline in Body Weight at Week 24 | Sotagliflozin 400 mg | -2.67 | Standard Error 0.188 | kilograms (kg) | |
| Change From Baseline in Mean Daily Bolus Insulin Dose at Week 24 | Placebo | -0.84 | Standard Error 0.688 | IU/day | |
| Change From Baseline in Mean Daily Bolus Insulin Dose at Week 24 | Sotagliflozin 200 mg | -2.33 | Standard Error 0.692 | IU/day | |
| Change From Baseline in Mean Daily Bolus Insulin Dose at Week 24 | Sotagliflozin 400 mg | -4.13 | Standard Error 0.692 | IU/day | |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24 | Placebo | 0.21 | Standard Error 0.191 | millimole per liter (mmol/L) | |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24 | Sotagliflozin 200 mg | -0.34 | Standard Error 0.192 | millimole per liter (mmol/L) | |
| Change From Baseline in Fasting Plasma Glucose (FPG) at Week 24 | Sotagliflozin 400 mg | -0.78 | Standard Error 0.193 | millimole per liter (mmol/L) | |
| Change From Baseline in Diabetes Total Treatment Satisfaction Scores as Measured by Total Diabetes Treatment Satisfaction Questionnaire Status (DTSQs) Scores at Week 24 | Placebo | -0.4 | Standard Error 0.30 | units on a scale | |
| Change From Baseline in Diabetes Total Treatment Satisfaction Scores as Measured by Total Diabetes Treatment Satisfaction Questionnaire Status (DTSQs) Scores at Week 24 | Sotagliflozin 200 mg | 2.1 | Standard Error 0.31 | units on a scale | |
| Change From Baseline in Diabetes Total Treatment Satisfaction Scores as Measured by Total Diabetes Treatment Satisfaction Questionnaire Status (DTSQs) Scores at Week 24 | Sotagliflozin 400 mg | 2.1 | Standard Error 0.31 | units on a scale | |
| Change From Baseline in Diabetes Distress Scores as Measured by 2-item Diabetes Distress Screening Scale (DDS2) Scores at Week 24 | Placebo | 0.3 | Standard Error 0.11 | units on a scale | |
| Change From Baseline in Diabetes Distress Scores as Measured by 2-item Diabetes Distress Screening Scale (DDS2) Scores at Week 24 | Sotagliflozin 200 mg | -0.4 | Standard Error 0.11 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02384941/results